Hypoglycemia in type 2 diabetes: Current controversies and changing practices

Zachary T. Bloomgarden, Daniel Einhorn

Research output: Contribution to journalShort surveypeer-review

13 Scopus citations


Hypoglycemia is well-recognized to limit the degree of glycemic control possible for many individuals for diabetes. Although the likelihood of hypoglycemia increases as A1c levels decrease in type 1 diabetes, insulin-treated type 2 diabetic persons with higher A1c appear paradoxically to have more hypoglycemia which may explain, in part, the adverse outcome reported in the ACCORD study. Approaches to glucose-lowering that cause lesser degrees of risk for hypoglycemia, technologies to better ascertain hypoglycemic events, and better understanding of patient characteristics associated with greater likelihood of hypoglycemia will all be required to reduce this limiting factor in optimizing glycemic treatment.

Original languageEnglish
Article numberArticle 66
JournalFrontiers in Endocrinology
Issue numberMAY
StatePublished - 2012


  • Glycemic control
  • Hemoglobin A1c
  • Hypoglycemia
  • Insulin therapy
  • Type 2 diabetes


Dive into the research topics of 'Hypoglycemia in type 2 diabetes: Current controversies and changing practices'. Together they form a unique fingerprint.

Cite this